KRMDRepro Med Systems, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · korumedical.com

3.210USD-3.31%Mkt Cap: 148.21M $P/E: —3d ago

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the F…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap148.21M $

Enterprise Value146.00M $

Revenue (TTM)45.11M $

Gross Profit25.60M $

Net Income (TTM)-2.64M $

Revenue/Share0.9750 USD

Last Price3.210 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees73

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)93.43

PEG—

EV/EBITDA-149.07

EV/Revenue3.24

P/S3.33

P/B8.36

EPS (TTM)-0.04

EPS (Forward)0.04

52W Range

3.2100% of range6.608

52W High6.608 USD

52W Low3.210 USD

Profitability

Gross Margin62.26%

Oper. Margin5.21%

EBITDA Margin-2.17%

Profit Margin-6.41%

ROE-15.47%

ROA-9.35%

Growth

Revenue Growth18.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF462.40K $

CapEx (TTM)956.49K $

FCF Margin1.61%

FCF Yield0.49%

Net Debt-4.98M $

Net Debt/EBITDA5.08

Balance Sheet

Debt/Equity0.21

Current Ratio2.72

Quick Ratio2.00

Book Value/Sh0.3910 USD

Cash/Share0.1790 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)6.600 USD

Upside (mean)+105.6%

Target Range5.000 USD – 8.000 USD

$5.000+105.6% to mean$8.000

# Analysts5

Ownership

Shares Out.46.17M

Float34.48M

Insiders8.10%

Institutions56.45%

Short Interest

Short Ratio6.1d

Short % Float2.12%

Short % Out.1.74%

Shares Short800.75K

Short (prev mo.)678.48K

Technical

SMA 503.978 (-19.3%)

SMA 2004.556 (-29.5%)

Beta0.45

S&P 52W Chg18.16%

Avg Vol (30d)222.45K

Avg Vol (10d)316.49K

Technical Indicators

RSI (14)29.8

MACD-0.2245

MACD Signal-0.1735

MACD Hist.-0.0510

BB Upper4.456 USD

BB Middle3.721 USD

BB Lower2.986 USD

BB Width39.50%

ATR (14)0.2040 USD

Vol Ratio (20d)0.85x